# Huaige Capital

> Huaige Capital is a VC fund in Shanghai backing Medical and Health Care. See 23 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 23
- Last investment: Mar 2026
- Lead investor: 30%
- Last updated: Aug 2026
- Website: http://en.huaigecapital.com

Huaige Capital is a venture capital focusing on healthcare sector.

## Contacts

5 contacts available for Huaige Capital. Shizune tracks 1 team members at Huaige Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/huaige-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Angel | $425k–$14M |
| Series A | $2.8M–$36M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 9 | 39% |
| Health Care | 9 | 39% |
| Biotechnology | 9 | 39% |
| Pharmaceutical | 6 | 26% |
| Biopharma | 5 | 22% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 9 | 39% |
| Angel | 6 | 26% |
| Seed | 2 | 9% |
| Series B | 1 | 4% |
| Series C | 1 | 4% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kai Wang | Founder | 0 | https://shizune.co/investors/profile/kai-wang-91b6 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xianyan Biopharma | Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff. | $21.8M | Series A | Mar 20, 2026 |  |
| Heerkang | Heerkang is a medical technology company that provides medical device research and sales, and health consultation services. |  | Series A | Nov 04, 2025 |  |
| Yili Pharmaceutical | Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14M | Angel | Sep 25, 2025 |  |
| Venus Medical | Venus Medical develops medical aesthetic products using silk fibroin gene editing and ECM-like matrix technology, offering three filler injections and two dressings. |  | Seed | Sep 10, 2025 |  |
| Xianyan Biopharma | Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff. | $14.1M | Venture - Series Unknown | Aug 29, 2024 |  |
| Xinhengrui Medical | Xinhengrui Medical provides heart-assisted medical devices and offers complete, safe, and effective intelligent mechanical-assisted therapy solutions for heart failure patients. | $13.9M | Series A | Jul 17, 2023 |  |
| Affinity | Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs. |  | Series B | Jul 06, 2023 |  |
| Yineng Pharma | Eneng Medicine is a national high-tech enterprise focusing on the development of new Chinese medicines and natural medicines. | $14.6M | Series A | Mar 30, 2023 |  |
| Enochic | Enochic is a synthetic biology platform provider. | $7.1M | Angel | Jan 05, 2023 |  |
| Enokiko | Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $7.3M | Angel | Jan 05, 2023 |  |

10 of 23 investments shown.

## Co-investors
- [Jingsheng Capital](https://shizune.co/investors/profile/jingsheng-capital) — VC Fund, 2 deals together
- [Jiuye Juntian Venture Capital](https://shizune.co/investors/profile/jiuye-juntian-venture-capital) — VC Fund, 2 deals together
- [ALAN AMC](https://shizune.co/investors/profile/alan-amc) — VC Fund, 1 deal together
- [Anjie Zhengjuan](https://shizune.co/investors/profile/anjie-zhengjuan) — VC Fund, 1 deal together
- [Beijing Hankang Chuangye Touzi](https://shizune.co/investors/profile/beijing-hankang-chuangye-touzi) — VC Fund, 1 deal together
- [Biocity Jingchuang](https://shizune.co/investors/profile/biocity-jingchuang) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Unilever Ventures](https://shizune.co/investors/profile/unilever-ventures) — VC Fund
- [Fab Co-Creation Studio Ventures](https://shizune.co/investors/profile/fab-co-creation-studio-ventures) — VC Fund
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)
- [Beauty VC Funds in Asia](https://shizune.co/investors/beauty-vc-funds-asia)
- [Beauty Investors in China](https://shizune.co/investors/beauty-investors-china)
- [Beauty VC Funds in China](https://shizune.co/investors/beauty-vc-funds-china)

## FAQ

### What does Huaige Capital invest in?

Huaige Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Angel stage. Most of the 23 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Huaige Capital's check size?

Huaige Capital typically joins rounds of $425k–$14M at Angel and $2.8M–$36M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Huaige Capital participates in.

### How do I contact Huaige Capital?

Public channels for Huaige Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Huaige Capital?

The team at Huaige Capital includes Kai Wang (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co